DE3579655D1 - Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3. - Google Patents

Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.

Info

Publication number
DE3579655D1
DE3579655D1 DE8585112679T DE3579655T DE3579655D1 DE 3579655 D1 DE3579655 D1 DE 3579655D1 DE 8585112679 T DE8585112679 T DE 8585112679T DE 3579655 T DE3579655 T DE 3579655T DE 3579655 D1 DE3579655 D1 DE 3579655D1
Authority
DE
Germany
Prior art keywords
medical
containing active
external use
active vitamin
use containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585112679T
Other languages
English (en)
Inventor
Yuji Makino
Yoshiki Suzuki
Takashi Aoyagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20963184A external-priority patent/JPS6187619A/ja
Priority claimed from JP16289385A external-priority patent/JPS6226223A/ja
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE3579655D1 publication Critical patent/DE3579655D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE8585112679T 1984-10-08 1985-10-07 Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3. Expired - Lifetime DE3579655D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20963184A JPS6187619A (ja) 1984-10-08 1984-10-08 活性型ビタミンｄ↓３類外用剤
JP16289385A JPS6226223A (ja) 1985-07-25 1985-07-25 乾癬治療剤

Publications (1)

Publication Number Publication Date
DE3579655D1 true DE3579655D1 (de) 1990-10-18

Family

ID=26488518

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585112679T Expired - Lifetime DE3579655D1 (de) 1984-10-08 1985-10-07 Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.

Country Status (6)

Country Link
US (1) US4871723A (de)
EP (1) EP0177920B1 (de)
CA (1) CA1272953A (de)
DE (1) DE3579655D1 (de)
FR (1) FR99C0035I2 (de)
MY (1) MY101544A (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037816A (en) * 1984-11-02 1991-08-06 The General Hospital Corporation Method of treating psoriasis
US4728643A (en) * 1984-11-02 1988-03-01 The General Hospital Corporation Method of treating psoriasis
IL74617A (en) * 1985-03-15 1988-11-15 Yeda Res & Dev Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
PH26083A (en) * 1987-11-09 1992-02-06 Sandoz Ltd 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
JP2856444B2 (ja) * 1989-07-28 1999-02-10 呉羽化学工業株式会社 ビタミンｄ▲下３▼代謝産物製剤
US5254538A (en) * 1989-10-04 1993-10-19 Trustees Of Boston University Method of treating periodontal disease
US5061700A (en) * 1989-11-16 1991-10-29 Gordon Jay Dow Glyceryl acetate ointment vehicles
DK0437225T3 (da) * 1990-01-10 1994-06-27 Hoffmann La Roche Topiske præparater
WO1991012792A1 (en) * 1990-03-02 1991-09-05 The Partnership Of Isaac G. Eliaz And Shmuel Gonen Method and product for promoting hair growth and treating skin conditions
US6203782B1 (en) 1990-03-02 2001-03-20 Universal Biologics, Inc. Method and product for promoting hair growth and treating skin conditions
ES2070307T3 (es) * 1990-07-04 1995-06-01 Marcin Krotkiewski Una preparacion para el tratamiento de la hipertension.
AU653026B2 (en) * 1991-06-07 1994-09-15 Teikoku Seiyaku Kabushiki Kaisha Physiologically active polypeptide-containing pharmaceutical composition
US5486509A (en) * 1991-06-28 1996-01-23 University Of Miami Method of preventing and treating chemotherapy-induced alopecia
EP0581587A3 (de) * 1992-07-31 1995-05-17 Tanabe Seiyaku Co Grundstoff zur transdermalen Verabreichung.
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
WO1995006482A1 (fr) * 1993-09-01 1995-03-09 Teijin Limited COMPOSITION D'EMULSION A BASE DE 1α,24-(OH)2-VITAMINE D¿3?
FR2710841B1 (fr) * 1993-10-05 1995-11-17 Oreal Composition cosmétique ou pharmaceutique pour la peau, anhydre et stable, à base de rétinol et son utilisation en vue du traitement des maladies de la peau.
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
AU710931B2 (en) * 1996-02-28 1999-09-30 Sumitomo Pharmaceuticals Company, Limited Crystalline vitamin D derivative
US5939090A (en) * 1996-12-03 1999-08-17 3M Innovative Properties Company Gel formulations for topical drug delivery
US6432422B1 (en) * 1997-12-09 2002-08-13 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
CA2312060A1 (en) 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
US6187763B1 (en) * 1998-03-04 2001-02-13 Teijin Limited Activated vitamin D3 emulsion-type lotions
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises
EP1874320A1 (de) * 2005-04-19 2008-01-09 Galderma S.A. Zusammensetzung für eine filmbildende lösung mit vitamin d oder einem derivat davon und einem corticosteroiden und ihre verwendung in der dermatologie
FR2884419B1 (fr) * 2005-04-19 2007-06-22 Galderma Sa Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
BRPI0609630A2 (pt) 2005-05-10 2010-04-20 Dermipsor Ltd composições e métodos para tratamento de doenças epidérmicas hiperproliferativas
FR2885527B1 (fr) * 2005-05-16 2007-06-29 Galderma Res & Dev Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
AU2006253913B2 (en) * 2005-06-01 2010-09-16 Mayne Pharma Llc Vitamin formulation
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (de) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topische Zusammensetzung mit Vitamin D und Kortikosteroid
EP2008651A1 (de) 2007-06-26 2008-12-31 Drug Delivery Solutions Limited Biologisch erodierbares Patch
BR112013023458B1 (pt) 2011-03-14 2020-04-07 Drug Delivery Solutions Ltd composição oftálmica, e, método para fabricar a composição oftálmica
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
EP3542788A1 (de) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249109A (en) * 1963-11-01 1966-05-03 Maeth Harry Topical dressing
GB1404583A (en) * 1971-10-08 1975-09-03 Vymatt Sa Urea compositions and methods of preparation thereof
DE2249414A1 (de) * 1972-10-09 1974-04-25 Georg Dr Rueckheim Brand- und wundsalbe
US3901928A (en) 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US4022891A (en) 1974-06-18 1977-05-10 Teijin Limited Novel 1α,24-dihydroxycholecalciferol compositions, novel precursors thereof, and processes for preparing them
FR2389377A1 (en) * 1977-05-06 1978-12-01 Brohult Johan Antiinflammatory, antirheumatic medicament - comprises 1 alpha-hydroxy-cholecalciferol
JPS5452717A (en) * 1977-09-29 1979-04-25 Chugai Pharmaceut Co Ltd Stable oily pharmaceuticals containing 1alpha-hydroxyvitamin d
US4230701A (en) * 1979-03-21 1980-10-28 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JPS55136229A (en) * 1979-04-10 1980-10-23 Teijin Ltd Adjustment of bone metabolism in warm-blooded animal and drug for it
JPS5626820A (en) 1979-08-10 1981-03-16 Chugai Pharmaceut Co Ltd Immunosuppressing agent
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
JPS57149224A (en) 1981-03-13 1982-09-14 Chugai Pharmaceut Co Ltd Tumor-suppressing agent
US4338312A (en) * 1981-05-11 1982-07-06 Wisconsin Alumni Research Foundation Method for preventing parturient paresis in dairy cattle
US4442093A (en) * 1981-05-15 1984-04-10 Kureha Kagaku Kogyo Kabushiki Kaisha Method for administering 24,25-dihydroxycholecalciferol to persons suffering from hypercalcemia
EP0094644B1 (de) * 1982-05-17 1986-07-30 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verwendung eines Cholecalciferolderivates
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
FR2530624B1 (fr) * 1982-07-26 1987-08-07 Wisconsin Alumni Res Found Nouveaux analogues de la vitamine d et compositions pharmaceutiques ou veterinaires les contenant
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS6011422A (ja) * 1983-06-30 1985-01-21 Kureha Chem Ind Co Ltd 抗筋ジストロフイ−症剤
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPS6217A (ja) * 1985-02-14 1987-01-06 Chugai Pharmaceut Co Ltd 安定な活性型ビタミンｄ３類製剤

Also Published As

Publication number Publication date
US4871723A (en) 1989-10-03
MY101544A (en) 1991-12-17
EP0177920A2 (de) 1986-04-16
EP0177920B1 (de) 1990-09-12
FR99C0035I1 (de) 1999-11-05
CA1272953A (en) 1990-08-21
FR99C0035I2 (de) 2000-08-11
EP0177920A3 (en) 1987-06-03

Similar Documents

Publication Publication Date Title
DE3579655D1 (de) Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.
DE3578620D1 (de) Arzneimittel zur aeusserlichen anwendung.
FI853635L (fi) Oftalmologiskt instrument foer maetning av oegats interna vaetsketryck.
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
DE3586959D1 (de) Desinfektionsverfahren sowie zusammensetzung dafuer.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
FI851633L (fi) Kirurgiskt reparationsnaet.
DE3580304D1 (de) Arzneimittel.
NO874869D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
FI873087A0 (fi) Desensiterande dentalkomposition.
FI853111L (fi) Medicinskt haeftplaoster.
NO165786C (no) Festebandasje.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
FI850946L (fi) Medicinska plaoster.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO158460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
DK182388D0 (da) Forbindelsesorgan,isaer til medicinsk brug
NO844037L (no) Tannbehandlingspreparat inneholdende fluoridioner.
NO893329D0 (no) Fremgangsmaate for fremstilling av titanoksyd.
DE3680838D1 (de) Stabilisierte menschliche prourokinase.
FI860209A0 (fi) Engaongselektrod foer undersoekning av en patient.
FI853977L (fi) Icke-metallisk kirurgisk taong.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
DE69017231D1 (de) Hautpräparat zur äusserlichen anwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
V448 Application of spc

Free format text: PRODUCT NAME: TACALCITOLMONOHYDRAT; REGISTRATION NO/DATE: 34120.00.00, 19960610

Spc suppl protection certif: 196 75 022

Filing date: 19960724

V457 Spc granted

Free format text: PRODUCT NAME: TACALCITOLMONOHYDRAT; REGISTRATION NO/DATE: 34120.00.00, 19960610

Spc suppl protection certif: 196 75 022

Filing date: 19960724

V464 Spc expired

Free format text: PRODUCT NAME: TACALCITOLMONOHYDRAT; REGISTRATION NO/DATE: 34120.00.00, 19960610

Spc suppl protection certif: 196 75 022

Filing date: 19960724